Decoy Therapeutics Inc (DCOY) insider trading
Every open-market stock purchase and sale by Decoy Therapeutics Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- No open-market insider trades in the last 12 months.
- No open-market insider buys on record.
Last 12 months: insiders bought $0 (0 buys) and sold $0 (0 sales). Last close $2.88 on Sep 3, 2026.
Recent DCOY insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Aug 31, 2026 | Patricia G. Gauthier (Insider) | Bought (not open market) | — |
| Aug 31, 2026 | Peter Klaus Marschel (C-suite exec) | Bought (not open market) | — |
| Aug 31, 2026 | Barbara Louise Hibner (C-suite exec) | Bought (not open market) | — |
| Aug 31, 2026 | William K. McVicar (Insider) | Bought (not open market) | — |
| Aug 31, 2026 | Paul Lammers (Insider) | Bought (not open market) | — |
| Aug 31, 2026 | Mark J Rosenblum (CFO) | Bought (not open market) | — |
| Aug 31, 2026 | Tess Burleson (Insider) | Bought (not open market) | — |
| Aug 31, 2026 | Arnold C Hanish (Insider) | Bought (not open market) | — |
| Aug 31, 2026 | Frederick Pierce II (CEO) | Bought (not open market) | — |
Who's trading DCOY
- Tess Burleson, Insider: other filings, last Aug 31, 2026
- Patricia G. Gauthier, Insider: other filings, last Aug 31, 2026
- Arnold C Hanish, Insider: other filings, last Aug 31, 2026
- Barbara Louise Hibner, C-suite exec: other filings, last Aug 31, 2026
- Paul Lammers, Insider: other filings, last Aug 31, 2026
- Peter Klaus Marschel, C-suite exec: other filings, last Aug 31, 2026
- William K. McVicar, Insider: other filings, last Aug 31, 2026
- Frederick Pierce II, CEO: other filings, last Aug 31, 2026
- Mark J Rosenblum, CFO: other filings, last Aug 31, 2026
Get free alerts when an insider at Decoy Therapeutics Inc files a new trade →